These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38085950)

  • 1. Treatment of Necrotizing Fasciitis With NovoSorb Biodegradable Temporizing Matrix and RECELL Autologous Skin Cell Suspension: A Case Series.
    Austin CL; Sodade OE; Harrison B; Causa K
    J Burn Care Res; 2024 Mar; 45(2):528-532. PubMed ID: 38085950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of a Full-Thickness Burn Injury With NovoSorb Biodegradable Temporizing Matrix and RECELL Autologous Skin Cell Suspension: A Case Series.
    Larson KW; Austin CL; Thompson SJ
    J Burn Care Res; 2020 Jan; 41(1):215-219. PubMed ID: 31765469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons Learned From Two Survivors of Greater Than 90% TBSA Full-Thickness Burn Injuries Using NovoSorb Biodegradable Temporizing Matrix™ and Autologous Skin Cell Suspension, RECELL™: A Case Series.
    Malkoc A; Wong DT
    J Burn Care Res; 2021 May; 42(3):577-585. PubMed ID: 33022032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstruction of an Anterior Cervical Necrotizing Fasciitis Defect Using a Biodegradable Polyurethane Dermal Substitute.
    Wagstaff MJ; Caplash Y; Greenwood JE
    Eplasty; 2017; 17():e3. PubMed ID: 28197297
    [No Abstract]   [Full Text] [Related]  

  • 5. Wound healing and dermal regeneration in severe burn patients treated with NovoSorb® Biodegradable Temporising Matrix: A prospective clinical study.
    Lo CH; Brown JN; Dantzer EJG; Maitz PKM; Vandervord JG; Wagstaff MJD; Barker TM; Cleland H
    Burns; 2022 May; 48(3):529-538. PubMed ID: 34407914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with NovoSorb® Biodegradable Temporising Matrix in reconstruction of complex wounds.
    Li H; Lim P; Stanley E; Lee G; Lin S; Neoh D; Liew J; Ng SK
    ANZ J Surg; 2021 Sep; 91(9):1744-1750. PubMed ID: 34085755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A consecutive case series of defects reconstructed using NovoSorb
    Solanki NS; York B; Gao Y; Baker P; Wong She RB
    J Plast Reconstr Aesthet Surg; 2020 Oct; 73(10):1845-1853. PubMed ID: 32563668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategic Use of Biodegradable Temporizing Matrix (BTM) in Wound Healing: A Case Series in Asian Patients.
    Chen AC; Lin TW; Chang KC; Chang DH
    J Funct Biomater; 2024 May; 15(5):. PubMed ID: 38786647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of the safety and effectiveness of the RECELL
    Holmes JH; Molnar JA; Shupp JW; Hickerson WL; King BT; Foster KN; Cairns BA; Carter JE
    Burns; 2019 Jun; 45(4):772-782. PubMed ID: 30578048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a synthetic biodegradable temporising matrix after necrotising fasciitis infection of the thigh.
    ALNafisee D; Casey MC; Kelly JL
    BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35835486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of NovoSorb biodegradable temporising matrix in wound management: a literature review and case series.
    Kidd T; Kolaityte V; Bajaj K; Wallace D; Izadi D; Bechar J
    J Wound Care; 2023 Aug; 32(8):470-478. PubMed ID: 37572341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a bilayer biodegradable synthetic dermal matrix for the management of defects arising from necrotising fasciitis.
    Barker T; Wagstaff M; Ricketts S; Bruscino-Raiola F
    J Wound Care; 2022 Sep; 31(9):724-732. PubMed ID: 36113547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novosorb® Biodegradable Temporising Matrix (BTM) and its Applications.
    Lim P; Li H; Ng S
    Surg Technol Int; 2023 Apr; 42():. PubMed ID: 37053370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term scarring outcomes and safety of patients treated with NovoSorb
    Lo CH; Wagstaff MJD; Barker TM; Damkat-Thomas L; Salerno S; Holden D; Concannon E; Heath K; Coghlan P; Cleland H
    JPRAS Open; 2023 Sep; 37():42-51. PubMed ID: 37360978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous Skin Cell Suspension for Full-Thickness Skin Defect Reconstruction: Current Evidence and Health Economic Expectations.
    Kahn SA; Carter JE; Wilde S; Chamberlain A; Walsh TP; Sparks JA
    Adv Ther; 2024 Mar; 41(3):891-900. PubMed ID: 38253788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstruction of Extensive Calvarial Exposure After Major Burn Injury in 2 Stages Using a Biodegradable Polyurethane Matrix.
    Greenwood JE; Wagstaff MJ; Rooke M; Caplash Y
    Eplasty; 2016; 16():e17. PubMed ID: 27222681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Analysis of Animal-Derived vs Fully Synthetic Acellular Dermal Matrices in Reconstructive Surgery: An Examination of Clinical, Aesthetic, and Economic Measures.
    Olsen T; Ali-Khan S; Bell D
    Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S172-S178. PubMed ID: 38556669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Necrotizing fasciitis of the hand and forearm : Acute surgical treatment and defect reconstruction with MatriDerm® and split-thickness skin graft].
    Niedermueller B; Singer G; Pickl P; Jesacher M
    Unfallchirurg; 2018 Mar; 121(3):256-260. PubMed ID: 29322228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparative Study of the ReCell® Device and Autologous Spit-Thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries.
    Holmes Iv JH; Molnar JA; Carter JE; Hwang J; Cairns BA; King BT; Smith DJ; Cruse CW; Foster KN; Peck MD; Sood R; Feldman MJ; Jordan MH; Mozingo DW; Greenhalgh DG; Palmieri TL; Griswold JA; Dissanaike S; Hickerson WL
    J Burn Care Res; 2018 Aug; 39(5):694-702. PubMed ID: 29800234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable Temporizing Matrix Reconstruction of Complex Perineal Burn Wound: A Case Report.
    Concannon E; Coghlan P; DamKat Thomas L; Solanki NS; Greenwood JE
    J Burn Care Res; 2021 Sep; 42(5):1038-1042. PubMed ID: 33889942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.